Fiduciary Trust Co

Bank

Position in HLN — Haleon plc

CIK 35442 Boston, MA

Position in HLN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$680,328

+$51,770 QoQ

Shares Held

67,965

+9.3% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2022

15 quarters on record

Voting authority Sole 94% Shared 0% None 6%

Healthcare · as of Mar 31, 2026

Fiduciary Trust Co holds $5,262,233 across 6 Drug Manufacturers - Specialty & Generic names. HLN ranks #3 (12.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	25,457	$3,009,271
2	SUPN	Supernus Pharmaceuticals, Inc.	14,714	$760,565
3	HLN	Haleon plc This page	67,965	$680,328
4	BCRX	Biocryst Pharmaceuticals Inc	42,955	$408,931
5	NBIX	Neurocrine Biosciences Inc	2,005	$264,138
6	AKBA	Akebia Therapeutics, Inc.	100,000	$139,000

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$680,328	67,965	+9.3%	Shares	Sole	2026-05-15
2025-12-31	$628,558	62,172	-4.5%	Shares	Sole	2026-02-13
2025-09-30	$584,063	65,113	+2.6%	Shares	Sole	2025-11-14
2025-06-30	$658,193	63,471	+2.5%	Shares	Sole	2025-08-14
2025-03-31	$637,269	61,931	+30.3%	Shares	Sole	2025-05-15
2024-12-31	$453,331	47,519	+13.3%	Shares	Sole	2025-02-14
2024-09-30	$443,872	41,954	+1.1%	Shares	Sole	2024-11-14
2024-06-30	$342,608	41,478	-1.4%	Shares	Sole	2024-08-14
2024-03-31	$356,978	42,047	+23.2%	Shares	Sole	2024-05-14
2023-12-31	$280,930	34,135	+8.4%	Shares	Sole	2024-02-12
2023-09-30	$262,228	31,480	-1.2%	Shares	Sole	2023-11-14
2023-06-30	$266,911	31,851	+18.2%	Shares	Sole	2023-08-01
2023-03-31	$219,429	26,957	+17.4%	Shares	Sole	2023-05-15
2022-12-31	$183,712	22,964	+51.0%	Shares	Sole	2023-02-14
2022-09-30	$92,604	15,206	—	Shares	Sole	2022-11-14
No filing history on record for this holder in this stock.